DNA X Q1 2026: asset sale nets $6.3M; no continuing revenue; raises $1.8M debt

DNA X, Inc.

Completed sale of mobile device assets to NEXA for $15M (net $13.5M after working capital adj); $12M paid, $1.5M due Oct 2026.
Net income of $6.3M from asset sale (taxes, fees, severance); no revenue from continuing operations.
G&A expenses from continuing ops $3.6M, including $1.5M severance and $0.9M audit/tax costs.
Cash from continuing ops $1.2M at quarter end; entered agreement for $1.8M new debt on May 20, 2026.
Rebranded from Sonim Technologies to DNA X, Inc.; focuses on AI/crypto trading platform.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.